Opening the door to the cause of myeloid leukemia: Finding the targets of common mutation


A drug that uses a unique ?double hit? to kill leukaemia cells could be a potential new treatment for patients with acute myeloid leukaemia. The research, majority funded by Cancer Research UK, is published this …